γ-Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct. - Ran Y; Hossain F; Pannuti A; Lessard CB; Ladd GZ; Jung JI; Minter LM; Osborne BA; Miele L; Golde TE (EMBO molecular medicine, 2017)